Chemical Structure (Aqvesme 1)
Aqvesme Tablet, Film Coated
Product Images NDC 71334-235
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aqvesme (NDC 71334-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Agios Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Aqvesme 2)
This text contains information about the average change from baseline in B concentration from Week 12 through Week 24, in terms of a/dL units. It compares AGVESE to Placebo (W4T). The baseline B concentration is specified, and it mentions the absence of data for certain subjects from Week 12 through Week 24. It also references a genetic subtype, a-chalassemia/ Mo disease.*
Figure 2 (Aqvesme 3)
Carton 100 mg (Aqvesme 4)
This text provides essential information about a medication called AQVESME™, which contains 100 mg of mitapivat sulfate per film-coated tablet. It provides guidance on storage conditions, recommended dosage, and the importance of keeping the tablets out of reach of children. The text also includes details about the manufacturer, contact information, and dosage instructions. Additionally, it indicates the shelf life of the tablets and emphasizes not to use them if the seal is broken or damaged. It is advised to swallow the tablets whole and not split, crush, chew, or dissolve them.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
